| Gene symbol | NCAM1 | Synonyms | CD56, MSK39, NCAM | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q23.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | neural cell adhesion molecule 1 | ||||
| GTO ID | GTC3506 |
| Trial ID | NCT05941156 |
| Disease | NK-Cell Leukemia | Nasal Type Extranodal NK/T-Cell Lymphoma |
| Altered gene | CD56 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD56 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Other ID(s) | XYFY2023-KL123-01 |
| Cohort 1 | |||||||||||
|
|||||||||||